Annual Cash & Cash Equivalents
$451.17 M
+$411.66 M+1042.04%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual cash & cash equivalents is $451.17 million, with the most recent change of +$411.66 million (+1042.04%) on December 31, 2023.
- During the last 3 years, MLTX annual cash & cash equivalents has risen by +$443.13 million (+5512.40%).
- MLTX annual cash & cash equivalents is now at all-time high.
Performance
MLTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$375.66 M
+$32.87 M+9.59%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly cash and cash equivalents is $375.66 million, with the most recent change of +$32.87 million (+9.59%) on September 30, 2024.
- Over the past year, MLTX quarterly cash and cash equivalents has increased by +$32.87 million (+9.59%).
- MLTX quarterly cash and cash equivalents is now -25.14% below its all-time high of $501.79 million, reached on June 30, 2023.
Performance
MLTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1042.0% | +9.6% |
| 3 y3 years | +5512.4% | +4573.0% |
| 5 y5 years | +5512.4% | +4573.0% |
MLTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5512.4% | -25.1% | +4573.0% |
| 5 y | 5-year | at high | +5512.4% | -25.1% | +4573.0% |
| alltime | all time | at high | +5512.4% | -25.1% | +4573.0% |
MoonLake Immunotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $375.66 M(+9.6%) |
| Jun 2024 | - | $342.79 M(-25.2%) |
| Mar 2024 | - | $458.44 M(+1.6%) |
| Dec 2023 | $451.17 M | $451.17 M(+41.8%) |
| Sep 2023 | - | $318.17 M(-36.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $501.79 M(+901.0%) |
| Mar 2023 | - | $50.13 M(+26.9%) |
| Dec 2022 | $39.51 M(+391.4%) | $39.51 M(-4.1%) |
| Sep 2022 | - | $41.20 M(-55.6%) |
| Jun 2022 | - | $92.71 M(+1053.3%) |
| Dec 2021 | $8.04 M | $8.04 M |
FAQ
- What is MoonLake Immunotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly cash and cash equivalents year-on-year change?
What is MoonLake Immunotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MLTX is $451.17 M
What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash & cash equivalents is $451.17 M
What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MLTX annual cash & cash equivalents has changed by +$411.66 M (+1042.04%)
What is MoonLake Immunotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MLTX is $375.66 M
What is the all time high quarterly cash and cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash and cash equivalents is $501.79 M
What is MoonLake Immunotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MLTX quarterly cash and cash equivalents has changed by +$32.87 M (+9.59%)